معرفی
Xin Zhou, PhD, is an Assistant Professor of Biological Chemistry & Molecular Pharmacology at Harvard Medical School and a faculty member in Cancer Biology at Dana-Farber Cancer Institute. Her research focuses on engineering signaling biomolecules to re-direct oncogenic and immune pathways in cancer. She joined DFCI in 2022 following a postdoctoral fellowship with Dr. James Wells at UCSF and a PhD under Dr. Michael Lin at Stanford University.
- Education: PhD (2017) in Chemical and Systems Biology, Stanford University; Postdoc (2017–2022), UCSF.
Her lab integrates biomolecular engineering, chemical biology, and synthetic biology to decode tumor microenvironment signaling, design conditionally active biologics, and target undrugged pathways. Key research areas include receptor tyrosine kinase signaling in lung cancer, immune checkpoint receptors in T cells/CAR-T cells, and G-protein coupled receptors in cancer and autoimmune diseases.
- Awards: K99/R00 Pathway to Independence Award, Damon Runyon Breakthrough Scientist Award, PEGS Summit Young Scientist Keynote.
Her work aims to address off-tumor toxicity in cancer therapies and develop novel diagnostic assays, such as a point-of-care SARS-CoV-2 antibody test. The Zhou Lab is based at Dana-Farber Cancer Institute (450 Brookline Ave, Boston).
